banner
New Risk Analysis
Welcome.  Sign in or register.
Refer A Friend | Contact Us
Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1053 U.S. listed China Stocks and Counting...
 Tracking 1536 U.S. Stocks and Counting...
Home
Market Activity
Shell Activity
Research
Message Boards
GeoBlog
About
Recent FilingsHighsLowsGainersLosersVolume LeadersGeoAlertsCorporate ActionsBusiness News

Documents shed light on pitfalls of China audits.

Monday, September 26, 2011, 12:00 AM ET - Washington, DC

 WASHINGTON, Sept 26 (Reuters) - When Michael Marks and John
Wang stepped off the board of directors of Jiangbo
Pharmaceuticals JGBO.O in June, they said goodbye to the
Chinese company with a 23-page resignation letter complaining
of months of unanswered questions, unpaid bills and management
deception. Full article.
Home  |   Market Activity  |   Research  |   Message Boards  |   My Account  |   Refer a Friend   |   Contact Us

About  |   Site Map  |   Privacy Policy  |   Terms of Service  |   Twitter  |   © 2009 GeoInvesting LLC


Articles | Asian Stock | Asian Stock Market | Asian Stocks | Business Outlook | Company Analysis | Company Profile
Day Trading | Stock Analysis| Stock Research


Statements and scenarios on GeoInvesting are not intended to be investment advice, but are based on some
commonly used investment guidelines. They are provided to aid investors in making their own investment decisions.
Please review GeoInvesting's complete disclosures and disclaimers under the link above regarding "Terms of Service."